The Wake Forest School of Medicine Alzheimer’s Disease Research Center (ADRC) focuses on research, education and treatment aimed at preventing Alzheimer’s disease and late-life cognitive decline.
The Wake Forest ADRC was awarded by the National Institute of Aging in 2016, joining a national network of Centers of Excellence at leading academic institutions. The mission of this network is to promote translational research to prevent and treat Alzheimer’s disease and other late-life neurodegenerative disorders. Our ADRC has a special focus on understanding the role of vascular and metabolic contributions to Alzheimer’s disease and on enhancing participation of underserved populations who are at increased risk.
The center also benefits our region by providing education to health professionals, researchers, patients and their families, and the community at large.
The goals of the ADRC are to:
- Establish a comprehensive research infrastructure to identify the causes of Alzheimer’s disease and potential prevention or treatment of the disease.
- Provide specialized resources to accelerate research into the role of metabolic and vascular factors in the causes of Alzheimer’s disease, while also encouraging research into the development of novel interventions.
- Improve the recruitment of African-American adults in research and educational programs to better understand and treat the causes underlying the increased risk of Alzheimer’s disease and dementia in the African-American population.
- Provide education regarding Alzheimer’s disease and related dementias to health professionals, researchers, patients and their families and the community at large.